Description

What is 5CLADBA ?

5CL-ADB-A (5-chloroadamantyl-benzylamine) is a synthetic research chemical belonging to the class of substituted adamantylamines.
It features:

• an adamantane core,

• a benzylamine group,

• and a chlorine substitution at the 5-position.

It is not approved for medical or human use and is supplied strictly for laboratory research and analytical purposes.

Chemical Profile & Structure

Chemical Name: 5-Chloro-adamantyl-benzylamine
Chemical Class: Substituted adamantanes
Molecular Formula: C₁₇H₂₂ClN
Appearance: White to off-white crystalline powder (depending on synthesis route and purity).

Adamantane-based compounds are often studied because of the structural stability and versatility of the adamantane scaffold.

Origin & Development

5CL-ADB-A is a relatively new compound with limited scientific documentation.
It likely emerged as:

• a structural analogue of other adamantane derivatives,

• a novel research molecule used in receptor studies,

• or a reference standard in forensic and analytical labs.

There is very little published data in peer-reviewed literature regarding its biological effects.

Potential Research Applications

5CLADBA may be used for:

• in vitro laboratory studies,

• analytical reference standards for GC-MS or LC-MS,

• forensic research involving identification of emerging synthetic compounds,

• basic neurochemical or receptor-binding investigations.

Its applications remain strictly experimental due to the lack of toxicological and pharmacological data.

Pharmacology (Not Fully Characterized)

There are no confirmed pharmacological studies describing how 5CLADBA interacts with biological systems.
Based on related adamantyl compounds, researchers speculate potential neurological activity — but no mechanism is verified.

There is:

• no clinical data,

• no toxicity data,

• no information on long-term effects,

• no validated safety profile.

As a result, the substance is classified as research-only.

Legality & Regulatory Status

Regulations vary by country.
In several jurisdictions, adamantane-based substances may fall under generic or analogue legislation, even if not explicitly scheduled.
In other regions, they remain unscheduled but still require clear labeling and compliance with chemical handling standards.

Any commercial distribution must include:

• “Not for human consumption” labeling,

• conformity with local chemical import laws,

• proper documentation and safety sheets (MSDS).

Safety Considerations

Because 5CL-ADB-A has no published toxicological data, all handling should be conducted using laboratory standards:

• protective gloves and eye protection

• dust mask or fume hood

• proper chemical storage

• waste disposal according to lab protocol

• use only by trained personnel

The lack of data means potential risks are unknown, and therefore extra caution is required.

Conclusion

5CL-ADB-A is a new and insufficiently studied adamantane-based research chemical.
Its pharmacological and toxicological properties are not established, and it must be handled exclusively for laboratory use with all appropriate safety measures.

5CLADBA is strictly for scientific use ONLY.